BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1826823)

  • 1. Endometrial hyperplasia. Clinico-pathological considerations of a prospective randomised study after abrasio only or high-dose gestagen treatment. Results of 2 years follow-up of 292 patients.
    Lindahl B; Willén R
    Anticancer Res; 1991; 11(1):403-6. PubMed ID: 1826823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometrical DNA measurements in endometrial hyperplasias. A prospective follow-up study after abrasio only or additional high-dose gestagen treatment.
    Lindahl B; Alm P
    Anticancer Res; 1991; 11(1):391-5. PubMed ID: 1826822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous endometrial hyperplasia. A 5 year follow-up of 82 patients after high-dose gestagen treatment.
    Lindahl B; Willén R
    Anticancer Res; 1994; 14(6B):2831-4. PubMed ID: 7872726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial hyperplasia: a prospective randomized study of histopathology, tissue steroid receptors and plasma steroids after abrasio, with or without high dose gestagen treatment.
    Lindahl B; Alm P; Fernö M; Norgren A
    Anticancer Res; 1990; 10(3):725-30. PubMed ID: 2142394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous endometrial hyperplasia. A prospective, 5 year follow-up of 246 patients after abrasio only, including 380 patients followed-up for 2 years.
    Lindahl B; Willén R
    Anticancer Res; 1994; 14(5B):2141-6. PubMed ID: 7840513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adjuvant gestagen therapy in stage I endometrial cancer].
    Lahousen M; Pickel H
    Zentralbl Gynakol; 1988; 110(16):1013-7. PubMed ID: 2973195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of endometrial activity after radiation therapy for cervical carcinoma.
    Barnhill D; Heller P; Dames J; Hoskins W; Gallup D; Park R
    Obstet Gynecol; 1985 Dec; 66(6):805-8. PubMed ID: 2999661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adjuvant hormone therapy in endometrial carcinoma: medroxyprogesterone acetate versus tamoxifen-medroxyprogesterone acetate sequential therapy].
    Vavra N; Salzer H; Sevelda P; Breitenecker G; Czerwenka K; Kucera H
    Gynakol Rundsch; 1990; 30(3):133-43. PubMed ID: 2147161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women.
    Ushijima K; Yahata H; Yoshikawa H; Konishi I; Yasugi T; Saito T; Nakanishi T; Sasaki H; Saji F; Iwasaka T; Hatae M; Kodama S; Saito T; Terakawa N; Yaegashi N; Hiura M; Sakamoto A; Tsuda H; Fukunaga M; Kamura T
    J Clin Oncol; 2007 Jul; 25(19):2798-803. PubMed ID: 17602085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment results of endometrial hyperplasia after prospective D-score classification: a follow-up study comparing effect of LNG-IUD and oral progestins versus observation only.
    Ørbo A; Arnes M; Hancke C; Vereide AB; Pettersen I; Larsen K
    Gynecol Oncol; 2008 Oct; 111(1):68-73. PubMed ID: 18684496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of long-term high-dose progesterone (Depo-Provera) therapy on endometrial carcinoma].
    Szarvas Z; Zsolnai B; Gimes G; Hidvégi J
    Morphol Igazsagugyi Orv Sz; 1985 Oct; 25(4):253-60. PubMed ID: 2933583
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology.
    Ross AH; Boyd ME; Colgan TJ; Ferenczy A; Fugere P; Lorrain J
    Obstet Gynecol; 1993 Nov; 82(5):773-9. PubMed ID: 8414325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of progestogens in the primary treatment of endometrial carcinoma.
    Macdonald RR; Thorogood J; Mason MK
    Br J Obstet Gynaecol; 1988 Feb; 95(2):166-74. PubMed ID: 2964861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progesterone receptors in endometrial carcinoma and their response to medroxyprogesterone acetate].
    Feng YJ; Zhang XY
    Zhonghua Fu Chan Ke Za Zhi; 1989 May; 24(3):153-5, 189. PubMed ID: 2530067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medroxyprogesterone acetate in adenomatous hyperplasia of the uterine endometrium. Clinical and morphologic studies on the duration and dosage of gestagen therapy].
    Dallenbach-Hellweg G; Czernobilsky B; Allemann J
    Geburtshilfe Frauenheilkd; 1986 Sep; 46(9):601-8. PubMed ID: 2945751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
    Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous endometrial hyperplasia. The prognostic significance of steroid receptor concentration. A two year follow-up of patients treated with abrasio only.
    Lindahl B; Fernö M; Norgren A; Willen R
    Anticancer Res; 1991; 11(5):1875-7. PubMed ID: 1768058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of fertility-preserving treatment in young women with endometrial carcinomas.
    Niwa K; Tagami K; Lian Z; Onogi K; Mori H; Tamaya T
    BJOG; 2005 Mar; 112(3):317-20. PubMed ID: 15713146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapy: a comparison of responses in patients treated with intrauterine levonorgestrel and systemic medroxyprogesterone.
    Vereide AB; Kaino T; Sager G; Ørbo A;
    Gynecol Oncol; 2005 Jun; 97(3):740-50. PubMed ID: 15885761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial hyperplasia following estrogen treatment without the addition of gestagen. A follow-up study after withdrawal of estrogens.
    Lindahl B; Willén R
    Anticancer Res; 1991; 11(6):2071-3. PubMed ID: 1776842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.